Trial intelligence / Profile preview

Zinc gluconate mouthwash for prevention of mucositis in patients with acute lymphoblastic leukemia

IRCT20190202042583N3Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Jun 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of zinc gluconate in acute lymphoblastic leukemia (ALL) and stomatitis, sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Prevention of mucositis. Started Jun 2019; status: completed.

02

Drugs

zinc gluconate
03

Conditions

acute lymphoblastic leukemia (ALL)stomatitis

Beyond the preview

Go deeper on IRCT20190202042583N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190202042583N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call